Search

A study conducted by researchers at Sichuan University focused on the impact of calf muscular vein thrombosis (CMVT) on the prognosis of geriatric hip fracture patients postoperatively. The study found that while there was no significant difference in mortality within one year postoperatively between patients with and without CMVT, those with CMVT experienced longer hospital stays, higher rates of postoperative complications, and increased thrombosis progression. The researchers recommended strategies such as close monitoring of thrombosis status, individualized care, and enhanced rehabilitation to optimize outcomes for this patient population. The study was published in BMC Geriatrics and can be accessed for free online. [Extracted from the article]

A recent study conducted at the Valley Vein Health Center in Turlock, California, focused on the incidence and management of venous thromboembolism (VTE) in rural patients undergoing varicose vein treatment. The research found that the incidence of VTE was low, with 45 cases out of 14,172 ultrasound-guided foam sclerotherapy (UGFS) procedures and 4865 radiofrequency ablation (RFA) treatments. Patients with a prior history of deep vein thrombosis (DVT) were at increased risk of developing VTE, and the modified Caprini risk score was identified as a useful tool for risk assessment. The study concluded that prior history of VTE poses a significant risk for recurrence in patients undergoing varicose vein treatments. [Extracted from the article]

Researchers at Southwest Medical University in Luzhou, China, recently reported a case of mechanical thrombectomy (MT) for refractory cerebral venous sinus thrombosis (CVST) in a child with nephrotic syndrome (NS). The 13-year-old boy with NS presented with acute headache and was found to have thrombus in multiple sinuses. After deteriorating on heparin therapy, the child underwent MT and showed improvement within 24 hours, ultimately recovering with normal neurological function. The study suggests that MT may be a viable option for refractory CVST in children with NS. [Extracted from the article]

Recent research from Tabriz University of Medical Sciences explores the association between Vitamin D deficiency and the risk of thrombotic disease. Vitamin D plays a crucial role in maintaining skeletal health and regulating calcium and phosphate metabolism. The study highlights the need for strategies to increase Vitamin D levels through dietary modifications and supplementation to prevent thrombotic events, especially among populations with limited exposure to sunlight. The findings suggest that low serum levels of Vitamin D may correlate with an increased risk of venous thromboembolism, although reported findings remain inconsistent. [Extracted from the article]

The article discusses the FRIENDS-01 clinical trial, which focuses on the treatment of Cancer Therapy Induced Thrombocytopenia (CTIT) using Romiplostim N01 compared to Recombinant Human Interleukin-11. The trial is interventional, in phase 3, and involves a randomized study design with no masking. The study aims to evaluate the efficacy and safety of the two treatments in patients with CTIT, with a primary completion date set for April 21, 2026. The trial is currently not yet recruiting participants, with eligibility criteria including age range, diagnosis of a malignant tumor, and specific platelet count requirements. The study is being conducted in China, with contact information provided for interested participants. [Extracted from the article]

Just-Evotec Biologics Inc. has been issued a patent for aflibercept formulations containing a lysine salt as a tonicifying agent for ophthalmic administration. Aflibercept is a recombinant fusion protein used in the treatment of various eye disorders, including macular edema and age-related macular degeneration. The patent outlines specific formulations of aflibercept with enhanced stability and favorable visual characteristics for intravitreal or topical administration in treating these eye disorders. [Extracted from the article]

Researchers at Second Military Medical University conducted a study on predicting pulmonary embolism (PE) using a machine learning algorithm. The study analyzed 1480 suspected PE patients and found that the random forest (RF) model had the highest efficacy in predicting outcomes, with an AUC of 0.776. The researchers designed a web page for the PE prediction model to aid in early diagnosis and treatment strategies. This study aims to enhance patient outcomes by optimizing the prediction and management of PE. [Extracted from the article]

A recent study conducted at Kyoto University Hospital in Japan focused on a case of Fat Embolism Syndrome (FES) treated with high-dose methylprednisolone. The study involved a 74-year-old woman who experienced acute pulmonary embolism post-orthopedic surgery, with no signs of pulmonary thromboembolism found on contrast computed tomography. Despite initial treatment with norepinephrine and dobutamine, the patient's hemodynamic status did not improve until high-dose methylprednisolone was administered, leading to prompt improvement. The research suggests the potential efficacy of high-dose methylprednisolone in improving hemodynamic status in cases of FES. [Extracted from the article]

Researchers at the Beijing Institute of Technology have developed a new computational thrombosis modeling approach to predict thrombus formation in aortic dissection patients post-stenting. The method utilizes a multiphase porous media theory to enhance predictive accuracy and reduce computational complexity, resulting in improved efficiency and clinical diagnosis capabilities. This study offers valuable insights for optimizing patient recovery and enhancing post-TEVAR prognostic evaluation. [Extracted from the article]

Researchers from Limoges University Hospital conducted a study on the prognostic value of incidental coronary artery calcifications (CAC) in patients undergoing computed tomography pulmonary angiography (CTPA) for suspected pulmonary embolism (PE). The study found that the presence of CAC independently predicted cardiovascular outcomes, including mortality, myocardial infarction, and coronary revascularization. The research suggests that assessing CAC in CTPA for suspected PE could provide valuable prognostic information beyond the initial PE diagnosis. The study was published in The American Journal of Cardiology and was peer-reviewed. [Extracted from the article]

Research from Lugano explores Budd-Chiari syndrome, a rare vascular disorder characterized by hepatic vein obstruction. The study discusses a case of a 26-year-old female with chronic Budd-Chiari syndrome and highlights the possible association with incomplete systemic lupus erythematosus. The importance of close monitoring and timely diagnosis to prevent disease progression is emphasized, with a focus on identifying symptoms of lupus erythematosus. The research underscores the need for further investigation and monitoring in such cases. [Extracted from the article]

A recent study from Ankara, Turkey, explored the prognostic value of total blood count parameter ratios in acute pulmonary embolism (PE). The study focused on the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean-platelet-volume-to-lymphocyte ratio (MPVLR) in 231 adult PE patients. High-risk patients showed elevated NLR and MPVLR, which correlated with ICU admission, intubation, and mortality. The NLR demonstrated the strongest prognostic value, suggesting these markers could improve risk stratification in PE patients. [Extracted from the article]

Researchers at Ghent University have developed a new method for constructing acoustic vulnerability curves in trees to better understand the impact of embolisms during drought. By using acoustic emission analysis, they were able to accurately quantify a tree's vulnerability to embolism formation, enhancing the accuracy of assessing drought stress. This method reduces subjectivity and offers broader insights into tree hydraulics, making it applicable across different species and environmental conditions. The study was published in Tree Physiology by Oxford University Press, and more information can be found by contacting the authors Kaat De Boeck and Kathy Steppe at Ghent University. [Extracted from the article]

Researchers in Esbjerg, Denmark, have conducted a study on atrial fibrillation (AF) and its association with stroke and systemic embolism. The study highlights the importance of balancing the risk of stroke and bleeding in patients with device-detected AF (DDAF) who may benefit from oral anticoagulant treatment. The research emphasizes the need for refining stroke risk assessment in patients with DDAF to optimize treatment strategies. For more information, readers can refer to the Journal of Clinical Medicine. [Extracted from the article]

A recent study from Kayseri City Hospital discusses the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder characterized by hemolytic anemia and thrombosis. The study highlights various treatment options, including stem cell transplantation and monoclonal antibodies approved by the FDA. Additional strategies focus on managing symptoms and complications of PNH, such as blood transfusions and iron replacement therapy. The research emphasizes the importance of anticoagulants and supplementation with folate, iron, and vitamin B12 to reduce the risk of thrombosis and support erythropoiesis. [Extracted from the article]

Researchers at the Indiana Hemophilia and Thrombosis Center published a study on a rare case of acquired factor V inhibitor (AFVwI) in a pediatric patient with venous thrombosis. The 13-year-old female patient with Crohn's Disease and May-Thurner anatomy was successfully treated with anticoagulation therapy, leading to the resolution of AFVwI and normalization of factor V activity. This case highlights the successful management of a pediatric thrombosis case with a rare complication, providing valuable insights for clinical practice. [Extracted from the article]

Vascular Medcure Inc. has been issued a patent for an axial lengthening thrombus capture system, tensioning system, and expandable funnel catheter. The invention aims to remove blood clots from the circulatory system to treat conditions like pulmonary embolism and deep vein thrombosis. The patent describes a capture system that can isolate and remove acute, subacute, and chronic blood clots using a shape memory tubular body and tensioners. This innovative device addresses limitations of current therapies and mechanical debulking techniques, offering a potentially more effective and less invasive treatment option for patients with vascular occlusions. [Extracted from the article]

A patent has been issued for a reduced thrombosis blood pump with a washout bearing by Boston Scientific Scimed Inc. The invention aims to prevent thrombus formation in circulatory support devices like blood pumps by incorporating washout blades to facilitate blood flow. The patent details the design and functionality of the bearing assembly and impeller assembly within the blood pump. This innovation addresses a critical issue in cardiovascular health and medical device technology. [Extracted from the article]

A patent application has been submitted for devices, systems, and methods to evaluate the acuteness of deep vein thrombosis (DVT) caused by blood clots in deep veins. The application aims to improve the accuracy of diagnosing acute versus chronic DVT, as traditional methods relying on patient interviews may be unreliable. The proposed method involves transmitting an ultrasound pulse into the blood clot, analyzing the strength of the ultrasound signal, and determining the acuteness of the clot based on this information. [Extracted from the article]

Researchers from Southwest Medical University in Luzhou, China, conducted a study using bioinformatics to identify biomarkers and immune infiltrates associated with deep vein thrombosis in patients with hip fractures. By analyzing gene expression profiles and immune cell data, they found that inflammatory responses regulated by immune cells like macrophages, B cells, and T cells play a significant role in venous thrombosis. The study highlighted the involvement of signaling pathways like Jak-STAT and HIF-1 in the disease process. This research provides valuable insights into the molecular mechanisms underlying deep vein thrombosis in patients with hip fractures. [Extracted from the article]

A recent study conducted in Richmond, Virginia, focused on the use of anticoagulation assays in pediatric patients undergoing extracorporeal membrane oxygenation (ECMO) treatment. The research found that discordance between activated partial thromboplastin time (aPTT) and anti-Factor Xa (AntiXa) levels is common and can impact patient outcomes. Specifically, titrating heparin based on AntiXa levels during discordant periods was associated with fewer bleeding and clotting events. The study highlights the importance of improved anticoagulation protocols for pediatric ECMO patients. [Extracted from the article]

University of Bahri researchers reported a rare case of a 34-year-old woman with a coexistence of Antiphospholipid Syndrome and Protein S Deficiency, leading to transverse sinus thrombosis. The patient presented with neurological symptoms, joint pain, hyperpigmentation, and a history of recurrent abortions. Tests revealed positive results for various antibodies and proteins associated with the conditions. This case highlights the unusual association between these two hypercoagulable states. [Extracted from the article]

A study conducted at the Medical University of South Carolina examined the utilization of extended pharmacologic venous thromboembolism prophylaxis after colorectal cancer resection. The research found that only 4.7% of patients received prophylaxis, with higher utilization rates in larger hospitals and National Cancer Institute designated hospitals. While prophylaxis was associated with decreased 30-day venous thromboembolism, overall adherence to guidelines was low, indicating a need for further investigation into factors influencing care practices. [Extracted from the article]

A recent study conducted at Tokyo Rinkai Hospital focused on the use of rivaroxaban in treating venous thrombosis in a patient with congenital antithrombin deficiency. The study found that continuous treatment with rivaroxaban led to rapid thrombus resolution and no recurrence for 15 months in a 39-year-old male patient. The research suggests that rivaroxaban may be effective in treating and preventing venous thromboembolism in patients with antithrombin deficiency. [Extracted from the article]

Researchers at the China-Japan Friendship Hospital conducted a study on the diagnostic accuracies of thromboelastography (TEG) combined with traditional coagulation parameters for detecting deep venous thrombosis (DVT) in elderly patients with hip fractures. The study found that TEG, when combined with traditional parameters, enhanced diagnostic capabilities for identifying perioperative thrombosis in this population. The research suggests that TEG could be valuable in establishing a more comprehensive diagnostic and predictive scoring system for DVT in elderly hip fracture patients. [Extracted from the article]

A recent study conducted at State University Campinas in Brazil utilized machine learning and artificial intelligence tools to analyze blood serum metabolites in patients with thromboembolism and antiphospholipid syndrome (APS). The research identified unique metabolic profiles that indicated significant alterations in glycolysis, the TCA cycle, lipid metabolism, and branched-chain amino acid metabolism, shedding light on the complex pathogenesis mechanisms of APS and thromboembolism. The study suggested that histidine, 3-hydroxybutyrate, and threonine could potentially serve as biomarkers to differentiate between APS, thromboembolism, and healthy controls. This research provides valuable insights into the potential use of metabolites as diagnostic tools for these conditions. [Extracted from the article]

A recent study conducted at University Hospital Bonn in Germany focused on assessing hypercoagulability in splanchnic vein thrombosis (SVT) by measuring the enzymes thrombin and activated protein C (APC). The study included 73 patients with SVT, with higher plasma levels of free thrombin and APC observed in patients with myeloproliferative neoplasms (MPNs) compared to healthy controls. The research suggests that APC may be a better biomarker for distinguishing SVT patients with MPNs than conventional indirect thrombin markers, potentially guiding anticoagulant therapy in the future. [Extracted from the article]

A recent study conducted by a researcher at Southern Medical University explored the association between social isolation and the risk of venous thromboembolism (VTE) among 236,026 participants. The study found that social isolation was positively associated with VTE risk, with a metabolic signature for social isolation mediating 11% of the increased risk. The research concluded that social isolation plays a role in VTE risk, and specific metabolites were identified as significant mediators of this association. [Extracted from the article]

A recent study from the School of Electronics Engineering introduces a new algorithm, the Modified-Net architecture, to enhance the segmentation of deep vein thrombosis (DVT) from medical images. The research aims to improve the precision of DVT region identification, achieving an accuracy of 98.92% and offering valuable insights into DVT segmentation. The study suggests that enhanced segmentation techniques can lead to improved clinical observation, treatment planning, and patient outcomes in the management of DVT. [Extracted from the article]

A recent study conducted by the Department of Neurology focused on understanding cerebral venous thrombosis (CVT) in males, a relatively rare disorder that affects about 5 persons per million per year with regional variations. The study found that smoking and alcoholism were major risk factors for CVT, with most patients showing improvement and only a small percentage experiencing poor outcomes such as deficits or mortality. The research highlights the varied clinical presentation of CVT and the importance of identifying risk factors for prevention and treatment. [Extracted from the article]

A recent study conducted at the Hospital for Sick Children in Toronto, Canada, focused on health literacy in pediatric patients with venous thrombotic events (VTEs). The research found that a majority of adolescents and parents/caregivers had low general health literacy levels and were not satisfied with their thrombosis-related knowledge. Adolescents tended to overestimate their knowledge, highlighting the need for effective strategies to support health literacy in this population. The study emphasizes the importance of improving health literacy to enhance self-management and health outcomes in pediatric patients with VTEs. [Extracted from the article]

A recent study from Ege University Faculty of Medicine sheds light on blood coagulation disorders, specifically focusing on Paget Schroetter Syndrome and a homozygous Factor V Leiden mutation. The study highlights a case of a 19-year-old female patient who presented with thrombosis in her right arm, attributed to intense physical activity and the genetic mutation. Treatment with low molecular weight heparin and oral anticoagulants proved effective in resolving the thrombus. The research emphasizes the importance of recognizing risk factors and utilizing appropriate therapies to prevent and treat thrombosis in such cases. [Extracted from the article]

Researchers from Majmaah University in Saudi Arabia have published new data on thrombosis, specifically focusing on a case report of thrombosed fetal dural sinus malformation. The study highlights the importance of timely fetal MRI in diagnosing dural sinus abnormalities and identifying intracranial complications. The research emphasizes the need for prenatal imaging to detect such abnormalities and determine appropriate perinatal management strategies. The study concluded that fetal intracranial thrombosis can result from dural sinus abnormalities, underscoring the significance of early detection and intervention in such cases. [Extracted from the article]

A study conducted at the Affiliated Hospital of Qingdao University compared the efficacy and safety of aspirin versus conventional therapy in preventing venous thromboembolism (VTE) after hip arthroplasty for femoral neck fracture. The research found that aspirin was noninferior to low-molecular-weight heparin followed by rivaroxaban in preventing VTE, with similar rates of bleeding events and other complications between the two groups. The study concluded that oral aspirin is a viable option for VTE prophylaxis in patients undergoing hip arthroplasty for femoral neck fractures. [Extracted from the article]

Researchers at the Department of Cardiology have reported on a case involving a 32-year-old woman with severe pulmonary embolism. Despite initial thrombolysis, the patient remained in cardiogenic shock, leading to the use of interventional thrombectomy with hemodynamic support by veno-arterial ECMO as a rescue strategy. The successful procedure resulted in immediate hemodynamic improvement, suggesting that interventional thrombectomy may be beneficial for high-risk pulmonary embolism cases that do not respond to thrombolytic therapy. The study highlights the importance of considering alternative treatment options in such critical situations. [Extracted from the article]

Researchers at the Medical University of Vienna have conducted a study on venous thromboembolism (VTE) and its association with biological aging, specifically focusing on telomeres. The study highlights the complexity of biological aging and the need for standardized methods to assess and validate biomarkers. The research provides insights into potential biomarkers for VTE and discusses future directions for investigating biological aging in relation to this cardiovascular condition. For more information, readers can access the full article in Biomedicines. [Extracted from the article]

A recent study conducted at the Medical University of Vienna explored the association between platelet count, fibrinogen, and D-Dimer levels with early stent thrombosis (ST) following percutaneous coronary intervention (PCI). The research found that patients with elevated platelet counts and fibrinogen levels were at a higher risk of early ST within 30 days after PCI. These findings suggest that preprocedural platelet counts and fibrinogen plasma levels could help identify patients at increased risk of early ST after DES implantation. The study was supported by the Ludwig Boltzmann Institute For Cardiovascular Research and published in the Journal of Clinical Medicine. [Extracted from the article]

University of Bristol researchers are investigating the association between tumor somatic mutations and venous thromboembolism (VTE) in cancer patients enrolled in the Genomics England 100,000 Genomes Project. The study aims to identify key genes involved in cancer-associated thrombosis and potentially contribute to genetic risk prediction models for these patients. The research is supported by Wellcome Trust and Cancer Research UK, and the findings may shed light on mechanistic pathways related to VTE in cancer patients. [Extracted from the article]

A study conducted by the Medical University of Vienna focused on managing patients with venous thromboembolism (VTE) and a high recurrence risk using the Vienna Prediction Model (VPM). The research found that anticoagulant therapy was effective and safe in patients with unprovoked VTE who were predicted to have a high risk of recurrence by the VPM. Patients who did not receive anticoagulation treatment had a significantly higher risk of VTE recurrence. The study highlights the importance of personalized risk assessment in determining the appropriate management of VTE patients. [Extracted from the article]

A recent study from the University of Toledo compared hospitalization rates for ischemic and hemorrhagic stroke in end-stage kidney disease (ESKD) and kidney transplant (KTx) patients with and without atrial fibrillation (AF). The research found that ESKD patients with AF had higher rates of ischemic stroke, while KTx patients with AF showed increased hospitalizations for hemorrhagic stroke. These findings highlight the impact of AF on hospitalization rates for cerebrovascular events in both ESKD and KTx patients. [Extracted from the article]

A study conducted at the International Hellenic University in Thessaloniki, Greece, focused on investigating genetic polymorphisms related to blood coagulation disorders in a Greek population. The research found that factor V Leiden and prothrombin mutations were predominantly wild types, while MTHFR polymorphisms showed higher variation in allele frequency. Lifestyle factors like smoking and high body mass index were associated with certain genetic combinations, indicating an interaction between genetic and environmental risk factors. The study concluded that these genetic variations not only impact thrombophilia but also have broader implications for cardiovascular disease and cancer, highlighting the need for further research into personalized preventive healthcare strategies. [Extracted from the article]

Researchers at the University of Ulsan in South Korea conducted a study on the use of the SUPERA stent to salvage arteriovenous grafts with early recurrent thrombosis after percutaneous transluminal angioplasty. The study included 20 patients who met specific criteria, and the results showed promising outcomes with high patency rates and low complication rates. The researchers concluded that the SUPERA stent could be effective in treating stenosis in AV grafts, particularly in the elbow or axilla region. The study was published in The Journal of Vascular Access and has been peer-reviewed. [Extracted from the article]

Researchers from Hospital Universitario in Madrid, Spain, have developed a predictive model using machine learning to assess the risk of occult cancer after a venous thromboembolism event. The study included 815 patients with VTE, with 6.9% being diagnosed with cancer during follow-up. The CatBoost algorithm showed the best performance in predicting hidden malignancy, with an ROC-AUC of 0.86 in the test set. The researchers emphasized the need for external validation of their risk score due to potential limitations in the study. [Extracted from the article]

A patent application titled "Methods Of Preventing A Venous Thromboembolic Event" was published online by inventors from Bossier City and Shreveport, Louisiana. The application focuses on preventing, treating, or alleviating symptoms of venous thromboembolic events by administering an endothelin receptor inhibitor, particularly an integrin alpha9 (ITGA9) inhibitor. The method targets conditions such as deep vein thrombosis, pulmonary embolism, and cancer-associated thrombosis, with a focus on patients undergoing anti-cancer therapeutic regimens. The application also suggests administering a thromboprophylaxis regimen with antithrombotic agents like warfarin, heparin, dabigatran, rivaroxaban, or apixaban. [Extracted from the article]

A recent study conducted by researchers at Baylor University College of Medicine focused on identifying clinical and genetic markers of vascular toxicities in glioblastoma (GBM) patients undergoing treatment. The study included 591 non-Hispanic White GBM patients, with findings indicating that hypertension was associated with improved survival, while corticosteroid use was a significant risk factor for thrombosis. The research suggests that future investigations should further explore the impact of corticosteroid use on thrombosis and the genetic risk of hypertension in other malignancies. [Extracted from the article]

Researchers from Tehran University of Medical Sciences conducted a meta-analysis comparing the efficacy and complication rates of low-dose (162 mg per day) versus high-dose (650 mg per day) aspirin for venous thromboembolic prophylaxis after total joint arthroplasty. The study found that while deep vein thrombosis (DVT) and pulmonary embolism (PE) rates were similar between the two groups, the total incidence of venous thromboembolism was significantly higher in the high-dose group. The research suggests that low-dose aspirin may offer comparable efficacy with a lower risk of periprosthetic joint infection (PJI) compared to high-dose aspirin regimens. [Extracted from the article]

A study conducted at the University of California Irvine examined the risk factors for venous thromboembolism (VTE) in patients undergoing endoscopic skull base surgery. The research found that short-term bed rest after surgery is not a significant risk factor for developing VTE in the immediate postoperative period. The study included 221 patients and concluded that factors such as age, sex, body mass index, and bed rest duration were not significant predictors of VTE. This research provides valuable insights into postoperative care for patients undergoing endoscopic skull base surgery. [Extracted from the article]

A study from Xuzhou Medical University in Jiangsu, People's Republic of China, focuses on acute superior mesenteric artery embolism (SMAE), a condition with a low incidence rate but high mortality due to rapid progression. The research emphasizes the importance of early diagnosis and timely surgical intervention to reduce mortality rates. The study highlights a case report of an 83-year-old female patient who recovered well following emergency surgical treatment for SMAE. The research suggests that computed tomography angiography (CTA) can provide a highly sensitive and specific diagnosis for SMAE, emphasizing the need for suspicion in patients with severe abdominal pain. [Extracted from the article]